Month: April 2020 (Page 6)

Brazil’s health authorities authorized the first medical cannabis product registered under rules created in December 2019, marking an important milestone for the industry in Latin America’s largest economy. The THC-free CBD product, registered to Brazilian pharmaceutical giant Prati-Donaduzzi, obtained “sanitary authorization” this week, according to a notice in the country’s official Gazette.Continue Reading

Marijuana Business Daily is debuting a virtual event series, MJBizDaily Direct, designed to offer industry executives and investors cannabis-focused content in a digital format during the coronavirus pandemic and beyond. The first events in this series will be MJBizConNEXT Direct and Hemp Industry Daily Conference Direct. The virtual conferences will runContinue Reading

Two members of the U.S. House of Representatives introduced legislation that would enable state-legal marijuana companies to qualify for U.S. Small Business Administration coronavirus relief programs, a stand-alone bill that could face an uphill battle in the current economic climate. State-legal marijuana companies and most ancillary businesses are shut outContinue Reading

Popularized by a recent Netflix documentary, the Wim Hof Method involves breathing exercises and exposure to extreme cold. So how does it relate to weed and your body’s endocannabinoid system? The post The stoner’s guide to the Wim Hof Method appeared first on Leafly. Read More: The stoner’sContinue Reading

‘Cannabis isn’t an antiviral medication,’ says a leading cannabinoid physician. ‘It doesn’t really function that way.’ The post Can cannabis prevent or cure the coronavirus? The data look dubious appeared first on Leafly. Read More: Can cannabis prevent or cure the coronavirus? The data look dubiousContinue Reading

A group of 10 U.S. senators is urging congressional leaders to include small, state-legal marijuana businesses and ancillary companies in any future coronavirus relief packages. Their letter follows a similar one last week signed by nearly three dozen members of the House of Representatives. Marijuana companies, including most ancillary businesses,Continue Reading